Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival

Transplantation Proceedings

Volumn 35, Issue 7, 2003, Pages 2477-2478

  Nanji, S A ^a   Hancock, W W ^b   Anderson, C C ^a   Zhu, L F ^a   Kneteman, N M ^a   Shapiro, A M J ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INDUCIBLE COSTIMULATORY MOLECULE ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0242637354     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.08.029     Document Type: Conference Paper

References (2)

1. Ozkaynak E., Gao W., Shemmeri N., et al. Nat Immunol. 2:2001;591.
2. Khayyamian S., Hutloff A., Buchner K., et al. Proc Natl Acad Sci USA. 99:2002;6198.